Stock Events

Asymchem Laboratories (Tianjin) 

€6.4
1
+€0.25+4.07% Heute

Statistik

Tag Hoch
-
Tag Tief
-
52W Hoch
-
52W Niedrig
-
Volumen
-
Durch. Volumen
-
Marktkap.
3.27B
KGV
15.9
Dividendenrendite
3.81%
Dividende
0.24

Demnächst

Dividenden

3.81%Dividendenrendite
10J Wachstumsrate
K.A.
5J Wachstumsrate
K.A.
3J Wachstumsrate
K.A.
1J Wachstumsrate
1.09%

Gewinne

25OctErwartet
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Weiter
0
0.94
1.89
2.83
Erwartetes EPS
1.3142766516
Tatsächliches EPS
K.A.

Leute folgen auch

Diese Liste basiert auf den Watchlists von Personen auf Stock Events, die 7K90.F folgen. Es handelt sich nicht um eine Anlageempfehlung.

Wettbewerber

Diese Liste ist eine Analyse basierend auf aktuellen Marktereignissen. Es ist keine Anlageempfehlung.

Über

Asymchem Laboratories (Tianjin) Co., Ltd. engages in the provision of contract development and manufacturing services focuses on innovation and commercial application of global pharmaceutical technology in Mainland China and internationally. The company offers research and development, and production services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; information technology services; and pharmaceutical science and technology development activities, as well as sale, wholesale, and retail of drugs. In addition, it is involved in the manufacture, development, and sale of medicine raw materials and relevant products; manufacture of chemical products; and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.
Show more...
CEO
Dr. Hao Hong Ph.D.
Mitarbeiter
9300
Land
CN
ISIN
CNE100004Z06
WKN
000A3C8W4

Börsen